About GENATLANTICA
GENATLANTICA Longevity Sciences is the European commercial entity of the Lynch Group, dedicated to pioneering advanced longevity solutions through cutting-edge, circadian-based protocols and scientifically validated formulations, proudly manufactured in Europe.
Our Mission
We exist to bridge the gap between advanced longevity research and accessible, high-quality consumer products. By leveraging the scientific heritage and proprietary technology of REGENEVIA LLC, GENATLANTICA brings to the European market a new generation of nutraceuticals designed around the science of chronobiology and epigenetics.
Our approach is compliance-first: every product we develop and distribute meets the highest standards of EU food supplement regulation, quality assurance, and consumer protection.
Leadership & Scientific Team
GENATLANTICA benefits from the same experienced leadership and scientific advisory team that drives the broader Lynch Group research programme.
| Name | Role |
|---|---|
| Dr. Giorgio S.C. Linchi | Founder & President — Lynch Group / REGENEVIA LLC |
| Dr.ssa Katia Memoli | Anti-Age Strategy & Scientific Direction |
| Dr. Marco Felli, MD | Head of Research — Regenerative Therapies |
| Dr.ssa Elvira Di Nucci, MD | Head of Research — Epigenetics |
| Dr.ssa Loredana Felli | Coordination & Logistics |
| Dr. Sergio Rosa | Logistics |
| Mr. Alex De Martino | Logistics & Communications — London Office |
| Lucilla Felli | Image & Marketing Strategy |
The Lynch Group
GENATLANTICA is part of the Lynch Group, an advanced scientific research consortium born from an idea conceived in 2016 with the establishment of Long Life Genetics in London. The group encompasses REGENEVIA LLC (research and intellectual property), GENATLANTICA (European commercial operations), and Solaris Cosmos (fundamental physics research).
REGENEVIA LLC holds a portfolio of five USPTO patent applications in the fields of epigenetic rejuvenation, autologous tissue engineering, and personalised biological formulations. GENATLANTICA operates under an exclusive technology licence from REGENEVIA, bringing this research heritage to the European consumer market.